Volume 19, Issue 9 p. 1102-1106
Clinical/Scientific Note

Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms

Kateřina Venderová PharmD, PhD,

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic

Search for more papers by this author
Evžen Růžička MD, DSc,

Corresponding Author

Movement Disorders Centre, Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czech Republic

Movement Disorders Centre, Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czech RepublicSearch for more papers by this author
Viktor Voříšek PharmD,

Division of Clinical Toxicology and Mass Spectrometry, Department of Biochemistry, University Hospital Hradec Králové, Czech Republic

Search for more papers by this author
Peter Višňovský MD, PhD,

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic

Search for more papers by this author
First published: 30 August 2004
Citations: 89

Abstract

An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit. © 2004 Movement Disorder Society